305 related articles for article (PubMed ID: 6246425)
21. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
22. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.
Creager MA; Halperin JL; Bernard DB; Faxon DP; Melidossian CD; Gavras H; Ryan TJ
Circulation; 1981 Sep; 64(3):483-9. PubMed ID: 6266691
[TBL] [Abstract][Full Text] [Related]
23. Accentuated vascular and endocrine response to SQ 20881 in hypertension.
Williams GH; Hollenberg NK
N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203
[TBL] [Abstract][Full Text] [Related]
24. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
25. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
[TBL] [Abstract][Full Text] [Related]
26. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
27. The erythrocyte sedimentation rate in congestive heart failure.
Haber HL; Leavy JA; Kessler PD; Kukin ML; Gottlieb SS; Packer M
N Engl J Med; 1991 Feb; 324(6):353-8. PubMed ID: 1987458
[TBL] [Abstract][Full Text] [Related]
28. Long-term control of congestive heart failure with captopril.
Fouad FM; Tarazi RC; Bravo EL; Hart NJ; Castle LW; Salcedo EE
Am J Cardiol; 1982 Apr; 49(6):1489-96. PubMed ID: 6803563
[TBL] [Abstract][Full Text] [Related]
29. [A clinical study of intravenous captopril in heart failure].
Wu H; Zhao HY
Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):161-4. PubMed ID: 8222978
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
Awan NA; Evenson MK; Needham KE; Win A; Mason DT
Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
[TBL] [Abstract][Full Text] [Related]
31. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia.
Dzau VJ; Packer M; Lilly LS; Swartz SL; Hollenberg NK; Williams GH
N Engl J Med; 1984 Feb; 310(6):347-52. PubMed ID: 6361570
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS
J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601
[TBL] [Abstract][Full Text] [Related]
34. [Effects of captopril on plasma renin activity angiotensin II and aldosterone level in cardiac failure patients].
Qin S; Ma C
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Feb; 19(1):29-31. PubMed ID: 2060462
[No Abstract] [Full Text] [Related]
35. Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
Hollenberg NK; Swartz SL; Passan DR; Williams GH
N Engl J Med; 1979 Jul; 301(1):9-12. PubMed ID: 221809
[TBL] [Abstract][Full Text] [Related]
36. Long-term treatment of congestive heart failure with captopril.
Komajda M; Eugene M; Evans J; Drobinski G; Laurenceau JL; Grosgogeat Y
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):223S-229S. PubMed ID: 6753904
[TBL] [Abstract][Full Text] [Related]
37. Improvement of chronic congestive heart-failure by oral captopril.
Turini GA; Brunner HR; Gribic M; Waeber B; Gavras H
Lancet; 1979 Jun; 1(8128):1213-5. PubMed ID: 87679
[TBL] [Abstract][Full Text] [Related]
38. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T
Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635
[No Abstract] [Full Text] [Related]
39. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
[TBL] [Abstract][Full Text] [Related]
40. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]